We are live on ! Find out more
RhumbLine Advisers

RhumbLine Advisers Portfolio holdings

AUM $117B
1-Year Est. Return 29.66%
This Fund
S&P 500
This Quarter Est. Return
+11.35%
1 Year Est. Return
+29.66%
3 Year Est. Return
+101.47%
5 Year Est. Return
+137.35%
10 Year Est. Return
+530.92%
AUM
$81.6B
AUM Growth
+$7.7B
Cap. Flow
+$798M
Cap. Flow %
0.98%
Top 10 Hldgs %
23.85%
Holding
3,095
New
53
Increased
1,513
Reduced
1,408
Closed
84

Top Buys

Rank Stock Value
1
MSFT icon
Microsoft
MSFT
+$65.3M
2
AMZN icon
Amazon
AMZN
+$50M
3
TSLA icon
Tesla
TSLA
+$30.5M
4
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$26.6M
5
EPAM icon
EPAM Systems
EPAM
+$26.3M

Sector Composition

Rank Sector Weight
1 Technology 25.54%
2 Financials 13.15%
3 Healthcare 12.95%
4 Consumer Discretionary 12.27%
5 Industrials 8.9%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ONL
1751
Orion Office REIT
ONL
$160M
$2.52M ﹤0.01%
+134,847
New +$2.66M
CYRX icon
1752
CryoPort
CYRX
$762M
$2.52M ﹤0.01%
42,511
-171
-0.4% -$11.8K
CNS icon
1753
Cohen & Steers
CNS
$4.3B
$2.51M ﹤0.01%
27,169
-252
-0.9% -$23.3K
NTGR icon
1754
NETGEAR
NTGR
$635M
$2.51M ﹤0.01%
85,982
-1,785
-2% -$53.2K
TGTX icon
1755
TG Therapeutics
TGTX
$7.62B
$2.5M ﹤0.01%
131,485
-1,460
-1% -$37.9K
CHRS icon
1756
Coherus Oncology
CHRS
$196M
$2.49M ﹤0.01%
156,108
-1,640
-1% -$28.7K
LILAK icon
1757
Liberty Latin America Class C
LILAK
$1.64B
$2.49M ﹤0.01%
240,073
-2,198
-0.9% -$24.2K
OCDX
1758
DELISTED
Ortho Clinical Diagnostics Holdings plc Ordinary Shares
OCDX
$2.49M ﹤0.01%
116,257
+10,786
+10% +$213K
TRS icon
1759
TriMas Corp
TRS
$1.44B
$2.49M ﹤0.01%
67,177
-1,324
-2% -$45.6K
CDNA icon
1760
CareDx
CDNA
$2.42B
$2.48M ﹤0.01%
54,649
-622
-1% -$32.5K
AHCO icon
1761
AdaptHealth
AHCO
$759M
$2.48M ﹤0.01%
101,502
+593
+0.6% +$13.9K
RC
1762
Ready Capital
RC
$308M
$2.48M ﹤0.01%
158,606
+2,816
+2% +$43.9K
NTUS
1763
DELISTED
Natus Medical Inc
NTUS
$2.48M ﹤0.01%
104,282
-71
-0.1% -$1.75K
LGF.B
1764
DELISTED
Lions Gate Entertainment Corp. Class B Non-Voting Shares
LGF.B
$2.47M ﹤0.01%
160,624
-1,215
-0.8% -$17K
MOV icon
1765
Movado Group
MOV
$841M
$2.47M ﹤0.01%
58,987
-3,460
-6% -$131K
VRRM icon
1766
Verra Mobility
VRRM
$744M
$2.47M ﹤0.01%
159,810
+2,083
+1% +$31.6K
AMRC icon
1767
Ameresco
AMRC
$1.36B
$2.46M ﹤0.01%
30,168
-110
-0.4% -$8.8K
COUR icon
1768
Coursera
COUR
$1.54B
$2.45M ﹤0.01%
100,244
+19,192
+24% +$584K
CASS icon
1769
Cass Information Systems
CASS
$743M
$2.44M ﹤0.01%
62,052
-270
-0.4% -$11.4K
GTN icon
1770
Gray Television
GTN
$552M
$2.44M ﹤0.01%
120,964
-1,932
-2% -$42.8K
IVR icon
1771
Invesco Mortgage Capital
IVR
$805M
$2.43M ﹤0.01%
87,299
+7,609
+10% +$236K
NX icon
1772
Quanex
NX
$1.01B
$2.42M ﹤0.01%
97,665
-878
-0.9% -$19.6K
PRDO icon
1773
Perdoceo Education
PRDO
$2.12B
$2.42M ﹤0.01%
205,486
+4,739
+2% +$51.7K
SC
1774
DELISTED
SANTANDER CONSUMER USA HOLDINGS INC
SC
$2.41M ﹤0.01%
57,390
-14
-0% -$586
EAF icon
1775
GrafTech
EAF
$212M
$2.41M ﹤0.01%
20,356
+246
+1% +$28.5K

Similar funds

RhumbLine Advisers's Q4 2021 Portfolio in Review

As of Q4 2021, RhumbLine Advisers held 3,095 positions worth $81.6B, up 10% from $73.9B the previous quarter. Its ten largest holdings account for 24% of the portfolio.

Trading was light in Q4 2021: portfolio turnover was 4.4%. RhumbLine Advisers opened 53 new positions and exited 84, leaving the 3,095-position portfolio largely intact.

By sector, the portfolio is most concentrated in Technology at 26% of assets, up from 24% a quarter earlier, followed by Financials and Healthcare.

  • RhumbLine Advisers's largest Q4 2021 buy was Rivian: 125,331 shares worth $13M.
  • RhumbLine Advisers added most to Microsoft in Q4 2021, an estimated $65.3M increase.
  • RhumbLine Advisers's biggest Q4 2021 reduction was Berkshire Hathaway Class B, cutting an estimated $21.9M.
  • RhumbLine Advisers fully exited Kansas City Southern in Q4 2021, selling an estimated $39.1M.
  • RhumbLine Advisers's ten largest holdings make up 24% of its $81.6B portfolio in Q4 2021.
  • RhumbLine Advisers opened 53 new positions and closed 84 in Q4 2021.
  • RhumbLine Advisers's portfolio value rose 10% quarter-over-quarter to $81.6B.

Based on RhumbLine Advisers's 13F filing for Q4 2021, filed 10 Feb 2022.